| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | 62.616 | 0 | 13.604 | 29.549 | 30.978 | 19.741 | 30.487 | 92.437 | 97.769 | 107.319 |
| Total Income - EUR | 64.046 | 0 | 17.603 | 27.649 | 31.272 | 19.747 | 30.487 | 92.437 | 97.778 | 108.021 |
| Total Expenses - EUR | 56.948 | 322 | 18.479 | 24.294 | 14.241 | 14.390 | 16.301 | 37.837 | 42.854 | 59.896 |
| Gross Profit/Loss - EUR | 7.098 | -322 | -875 | 3.354 | 17.031 | 5.357 | 14.186 | 54.600 | 54.924 | 48.126 |
| Net Profit/Loss - EUR | 5.213 | -322 | -1.011 | 2.873 | 16.178 | 4.833 | 13.451 | 52.936 | 53.966 | 45.794 |
| Employees | 3 | 1 | 2 | 2 | 1 | 1 | 0 | 1 | 1 | 1 |
Check the financial reports for the company - Ibormed S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | 24 | 23 | 1.914 | 1.552 | 1.200 | 862 | 535 | 1.376 | 924 | 5.284 |
| Current Assets | 11.417 | 11.030 | 13.180 | 12.597 | 28.464 | 33.387 | 25.254 | 57.569 | 63.860 | 52.195 |
| Inventories | 0 | 0 | 5.147 | 698 | 0 | 0 | 0 | 2.875 | 1.625 | 1.729 |
| Receivables | 0 | 64 | 3.830 | 1.642 | 2.646 | 5.193 | 4.702 | 8.417 | 56.848 | 35.153 |
| Cash | 11.417 | 10.966 | 4.203 | 10.257 | 25.818 | 28.194 | 20.552 | 46.277 | 5.387 | 15.313 |
| Shareholders Funds | 10.953 | 10.519 | 9.330 | 12.032 | 27.977 | 32.280 | 14.437 | 53.223 | 54.016 | 45.844 |
| Social Capital | 45 | 45 | 44 | 43 | 42 | 41 | 40 | 41 | 40 | 40 |
| Debts | 488 | 534 | 5.764 | 2.558 | 2.120 | 2.394 | 11.767 | 6.132 | 11.176 | 12.121 |
| Income in Advance | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 6 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "2521 - 2521" | |||||||||
| CAEN Financial Year |
4120
|
|||||||||
Comments - Ibormed S.r.l.